Breast Cancer

Our treatment approach for breast cancer is personalized based on the stage of the disease, your previous treatments, hormone receptor status, and your overall health. At Brio-Medical, we combine advanced integrative therapies with personalized care plans designed to support your body's natural healing processes while addressing your unique diagnosis.

Breast cancer may be supported through therapies such as immunotherapy, Low-Dose Metronomic Chemotherapy, targeted nutritional support, cellular revitalization, and other holistic treatments. Our goal is to strengthen the body's natural defenses, promote healing, and help improve quality of life throughout your cancer journey.

Every patient's treatment plan is individualized based on their diagnosis, stage of disease, prior treatments, treatment goals, and overall health. We believe the best outcomes begin with treating the whole person—not just the disease.

Our integrative treatment approach may include:

Immunotherapy: Dendritic Cell Therapy

• Helps educate the immune system to recognize cancer cells.
• Often considered as part of an individualized immunotherapy strategy.
• Frequently used alongside other integrative therapies.

Integrative Oncology: Low-Dose Metronomic Chemotherapy

• Low-dose chemotherapy administered using Low-Dose Metronomic Chemotherapy protocols.
• Designed to be part of an individualized integrative treatment plan.
• May be considered for appropriate patients alongside other therapies.

Holistic Therapy

Supportive therapies may include:

• Specific Natural IVs
• Repurposed Medications
• Clinical nutrition
• Targeted supplementation
• Hyperthermia
• Ozone therapy (if applicable)
• Detoxification support
• Mind-body therapies

Become a patient today and start your personalized holistic cancer treatment with expert guidance from our medical professionals. Call us at: 623-294-8096 or fill out the form and we'll reach out to you.

What Is Breast Cancer?

Breast cancer begins when abnormal cells develop in the tissues of the breast and grow uncontrollably. Most breast cancers start in either the milk ducts (ductal carcinoma) or the milk-producing glands called lobules (lobular carcinoma). If left untreated, these abnormal cells can invade nearby tissue and spread to other parts of the body.

Breast cancer often develops over time and may not produce noticeable symptoms in its earliest stages. This is why routine breast exams, mammograms, and early detection play an important role in identifying breast cancer before it has a chance to progress.

At Brio-Medical, we take an integrative approach to breast cancer by looking beyond the diagnosis alone. Factors such as immune health, nutrition, hormone balance, chronic inflammation, metabolic function, and overall wellness may all play an important role in supporting the body's natural healing processes. Our goal is to develop a personalized treatment plan that addresses the whole person while supporting the body's ability to heal and recover.

Types of Breast Cancer

Nearly 80% of breast cancers are invasive ductal carcinomas (IDC), which begin in the milk ducts and spread into the surrounding breast tissue. Another common type is invasive lobular carcinoma (ILC), which develops in the milk-producing glands, known as lobules. Together, these two types account for the vast majority of breast cancer diagnoses.

Less common types include ductal carcinoma in situ (DCIS), an early-stage, non-invasive form of breast cancer, triple-negative breast cancer (TNBC), which lacks estrogen, progesterone, and HER2 receptors, inflammatory breast cancer, Paget's disease of the breast, and other rare subtypes. Because each type of breast cancer behaves differently, developing a personalized treatment plan is an important part of every patient's care.

What Causes Breast Cancer?

Breast cancer develops when genetic changes occur in the cells of the breast, causing them to grow and divide uncontrollably. While the exact cause is not always known, breast cancer is believed to result from a combination of genetic, hormonal, environmental, and lifestyle factors that influence normal cell growth over time.

Research suggests that hormone balance, chronic inflammation, nutrition, environmental exposures, genetics, and overall health may all play a role in the development of breast cancer. Although some risk factors cannot be changed, maintaining a healthy lifestyle, staying physically active, and receiving regular breast cancer screening may help reduce your risk and improve the chances of early detection.

Factors that may increase your risk of developing breast cancer include:

• Being over the age of 50
• A family history of breast cancer or inherited BRCA1 or BRCA2 gene mutations
• A personal history of breast cancer or certain non-cancerous breast conditions
• Obesity and physical inactivity, particularly after menopause
• Long-term exposure to estrogen or hormone replacement therapy
• Smoking and excessive alcohol consumption
• Previous radiation exposure to the chest
• Dense breast tissue

Early Warning Signs and Symptoms of Breast Cancer

Many people with early-stage breast cancer experience few or no symptoms, which is why regular breast exams and mammograms play an important role in early detection. As the disease progresses, changes in the breast or surrounding tissue may become more noticeable. Common warning signs and symptoms of breast cancer include:

• A new lump or thickening in the breast or underarm
• Changes in the size or shape of the breast
• Swelling of all or part of the breast
• Skin dimpling or an orange peel-like appearance
• Nipple pain, inversion, or unusual discharge
• Redness, scaliness, or thickening of the nipple or breast skin
• Persistent breast pain or tenderness
• Swollen lymph nodes under the arm or near the collarbone
• Unexplained weight loss or persistent fatigue in more advanced stages

How to Diagnose and Stage Breast Cancer

Diagnosing breast cancer typically begins with a review of your symptoms, medical history, and a physical examination. A mammogram is the most common screening tool, often followed by a breast ultrasound, breast MRI, or biopsy to determine whether abnormal tissue is cancerous.

If breast cancer is diagnosed, additional tests such as CT scans, PET scans, bone scans, blood tests, or molecular and genetic testing may be recommended to determine whether the cancer has spread and to help guide personalized treatment planning.

The most widely used staging system for breast cancer is the TNM staging system developed by the American Joint Committee on Cancer (AJCC). Breast cancer is generally classified into four stages:

• Stage I – The cancer is small and confined to the breast with little or no lymph node involvement.
• Stage II – The tumor is larger and/or has spread to a small number of nearby lymph nodes.
• Stage III – The cancer has spread more extensively to nearby lymph nodes or surrounding tissues but not to distant organs.
• Stage IV – The cancer has spread to distant organs, most commonly the bones, liver, lungs, or brain.

References

1. American Cancer Society – Breast Cancer Overview
   Covers breast cancer basics, causes, risk factors, symptoms, diagnosis, treatment, and screening.
2. American Cancer Society – Types of Breast Cancer
   Reference for invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), DCIS, inflammatory breast cancer, Paget disease, and other breast cancer types.
3. American Cancer Society – Signs and Symptoms of Breast Cancer
   Source for common breast cancer symptoms and the importance of screening and early detection.
4. National Cancer Institute – How Breast Cancer Is Diagnosed
   Covers mammography, breast ultrasound, MRI, biopsy, staging tests, biomarker testing, and treatment planning.
5. National Cancer Institute – TNM Staging for Breast Cancer
   Explains the AJCC TNM staging system and how tumor size, lymph node involvement, and metastasis determine stage.
6. National Cancer Institute – Types of Breast Cancer
   Additional reference for molecular subtypes, including triple-negative breast cancer (TNBC), HER2-positive disease, inflammatory breast cancer, and other less common forms.